Patient (gender, age) | Year of enrolment | Parasitaemia (μL−1) | Enrolment HCT (%) | Antimalarial treatment | PCT (day) | Nadir HCT (%) [day] | Time of LAA (day) | LAnRT | Parasite reduction ratio (PRR) | Total of mg/kg dose of AA | Total of mg/kg dose of AL | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 1 | Day 2 | Artesunate | Amodiaquine | Artemether | Lumefantrine | |||||||||
124 (M, 2y) | 2010 | 12,648 | 25 | AL | 2 | 28 [28] | 28 | NAc | 1.2 × 101 | 1.3 × 104 | NA | NA | 10.9 | 65.5 |
15 (M, 1.2y) | 2008 | 72,815 | 27 | AL | 1 | 28 [28] | 21 | 14 | 7.3 × 104 | 7.3 × 104 | NA | NA | 17.4 | 102 |
46 (M, 0.8y) | 2015 | 16,979 | 27 | AA | 1 | 29 [21] | 21 | 7 | 1.7 × 104 | 1.7 × 104 | 15 | 40.5 | NA | NA |
58 (M, 2y) | 2010 | 19,647 | 28 | AL | 4 | 28 [28] | 28 | NAc | 7.6 × 100 | 2.5 × 102 | NA | NA | 8.6 | 51.4 |
15 (M, 1y) | 2014 | 29,714 | 30 | AL | 1 | 29 [28] | 28 | 7 | 3.0 × 104 | 3.0 × 104 | NA | NA | 8.6 | 51.4 |
100 (M, 1.3y) | 2010 | 118,344 | 30 | AL | 2 | 29 [21] | 21 | 7 | 3.5 × 101 | 1.2 × 105 | NA | NA | 13.3 | 80 |
64 (F, 1.9y)a | 2010 | 76,000 | 30 | AA | 2 | 29 [28] | 28 | NAc | 5.5 × 101 | 7.6 × 104 | 14.3 | 38.6 | NA | NA |
8 (F, 1y) | 2010 | 25,242 | 30 | AA | 2 | 28 [28] | 28 | NAc | 2.4 × 102 | 2.5 × 104 | 10.7 | 28.9 | NA | NA |
40 (F, 2y) | 2010 | 1,652 | 30 | AA | 1 | 28 [21] | 21 | 7 | 1.7 × 103 | 1.7 × 103 | 9.4 | 25.3 | NA | NA |
911 (M, 1.9y) | 2011 | 2,924 | 30 | AA | 1 | 28 [21] | 21 | 14 | 2.9 × 103 | 2.9 × 103 | 12.5 | 38.3 | NA | NA |
43 (M, 1.3y) | 2010 | 1,301 | 31 | AL | 1 | 27 [28] | 21 | NAc | 1.3 × 103 | 1.3 × 103 | NA | NA | 13.3 | 80 |
Mean | ||||||||||||||
Age (1.5y) |  | 15,569b | 28.9 |  | 1.6 | 28.3 | 24.2 | 9.3 | 6.6 × 102 | 1.0 × 104 | 12.4 | 34.3 | 12 | 71.7 |